Ladenburg Thalmann Financial Services’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | $953K | Buy |
15,649
+3,104
| +25% | +$189K | 0.01% | 1318 |
|
|
2019
Q3 | $514K | Buy |
12,545
+1,394
| +13% | +$57.1K | ﹤0.01% | 1745 |
|
|
2019
Q2 | $527K | Buy |
11,151
+117
| +1% | +$5.53K | ﹤0.01% | 1706 |
|
|
2019
Q1 | $395K | Buy |
11,034
+628
| +6% | +$22.5K | ﹤0.01% | 1873 |
|
|
2018
Q4 | $297K | Buy |
10,406
+1,855
| +22% | +$52.9K | ﹤0.01% | 1917 |
|
|
2018
Q3 | $380K | Buy |
8,551
+4,497
| +111% | +$200K | ﹤0.01% | 1814 |
|
|
2018
Q2 | $186K | Hold |
4,054
| – | – | ﹤0.01% | 2292 |
|
|
2018
Q1 | $186K | Buy |
4,054
+3,120
| +334% | +$143K | ﹤0.01% | 2292 |
|
|
2017
Q4 | $22K | Buy |
934
+300
| +47% | +$7.07K | ﹤0.01% | 3722 |
|
|
2017
Q3 | $11K | Buy |
634
+534
| +534% | +$9.27K | ﹤0.01% | 4021 |
|
|
2017
Q2 | $2K | Hold |
100
| – | – | ﹤0.01% | 4582 |
|
|
2017
Q1 | $2K | Buy |
+100
| New | +$2K | ﹤0.01% | 4547 |
|